Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M

Sensus Healthcare, Inc.

2024-Q2 EPS reported $0.24 revenue$19,902,000

Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.
Net income $1.6M ($0.10 diluted EPS) vs net loss of $0.4M ($0.02 loss per share) in Q2 2023.
Adjusted EBITDA $2.1M vs negative $1.0M in prior-year quarter.
Signed 15 Fair Deal Agreements for SRT-100 Vision units since March 2024; recurring revenue expected in 2025.
Cash and equivalents $19.0M, no debt; accounts receivable $18.3M vs $10.6M at Dec 31, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.